Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
NGM holding history
NGM Biopharmaceuticals Inc in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGM overviewAll 13F holders of NGMFull Q4 2024 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −500,000−100.0% | Sold out | Holders |
| Q3 2023 | 500,000 | $535.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 500,000 | $1.29M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 500,000 | $2.04M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 500,000 | $2.51M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 500,000 | $6.54M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2022 | 500,000 | $6.41M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 500,000 | $7.63M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2021 | 500,000 | $8.86M | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2021 | 500,000 | $10.5M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 500,000 | $9.86M | 0.3% | +500,000 | New | Holders |